Other stocks on watch this week
Future World Corp. (OTCBB: FWDG) is a provider of advanced solutions to the Cannabis industry. HempTech, a subsidiary of FutureWorld, is a technology division catered to the cannabis and the industrial Hemp market. HempTech provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal marijuana.
A few weeks ago the company CEO issued a report on FWDG’s business progress and future plans. Read the details in the report at this link: bit.ly/--FWDG-AnalystReport
ih.advfn.com/...=nmona&article=65192722&xref=newsalert
Published January 22nd, 2014
The following brief reports are provided only to attract new members to our site. We were not compensated in any way for the issuing of these brief reports.
Future World Corp. (OTCBB: FWDG) FULL REPORT
Dear Fellow Shareholders, as the CEO of FutureWorld, I would like to update all of you on our current business progress and upcoming events:
To reiterate my previous letter, we are currently involved in many “picks and shovel” ancillary business enterprises associated with the Hemp/Cannabis industry and will continue to delve even further as the space continues to evolve. Our overall strategy is to have a foot print in all states that have a legalized Hemp/Cannabis marketplace with diverse products and services. This will allow us to be at the forefront of this growth industry which may at some point surpass even the tobacco market, now worth close to $200 billion per year.
We are on the verge of creating perhaps the most enormous agricultural industry ever contemplated. Industrial Hemp alone could generate billions of dollars per year and create thousands of jobs. Cannabis, on the pharmaceutical level, will become a major competitor to the global trillion dollar pharmaceutical industry. We are living at a great point in history that may never repeat itself. Our job at FutureWorld is not only to become part of this history but also influence this history.
From the beginning we have decided, with total certainty, to be vertically integrated and cover the most important and profitable sectors of the cannabis market. Hence, we have developed business lines that have much better revenue trajectory than other segments of the industry. Of course, building a business in an industry that has just come into existence has not been easy, but that has only strengthened our resolve. We have had to invest heavily in the market segments that we deemed more profitable than others, while not neglecting our responsibility for the needs of the industry as a whole.
Since our last shareholder update, we have been able to monetize our investment in the segments of the market we have chosen. To summarize our accomplishments, I have categorized our discussion points in this shareholder letter based upon upcoming events and individual subsidiary business progress.
Upcoming Events – Revenue
Our third quarter (Q) ending December 31, 2014, will demonstrate the revenue trajectory of our company and our overall progress so far. It will show close to 140,000% increase in revenue from prior quarter ending December 31, 2013 and close to 550% increase in revenue from the second quarter 2014. Revenue increase was contributed by two of our subsidiaries; CB scientific and FutureLand properties. We expect the revenue trajectory to continue increasing momentum when all of our subsidiaries are running full throttle in the coming quarters.
Upcoming Events – Spin-Offs
Also per our business model, our goal has always been to return meaningful or even substantial ROI to our investors by spinning-off our subsidiaries. Hence, we have started the process of the spinning-off our first three subsidiaries in the coming months of 2015. These are CB scientific, HempTech, and URVape.
The spin-off shares of these three companies initially will be held by an independent trustee, subject to irrevocable instructions to distribute those shares to FutureWorld shareholders of record as of January 1, 2015, February 1, 2015, March 1, 2015, April 1, 2015 and May 1, 2015. The distributions will be made when the shares could be sold by the holders pursuant to an effective registration statement filed with the Securities and Exchange Commission or an exemption from such registration.
We have finished the initial process of our first spin-off, URVape, and starting the development of CB scientific and HempTech as we proceed further. We expect one to three spin-offs per year as we progress developing the business in this revolutionary burgeoning industry. We may consider speedier processes by reverse merging the subsidiaries if the right opportunity arises.
Subsidiaries Business Progress
1. FutureLand Properties, LLC.
\FutureLand Properties, LLC, closed on 237 acres in southern Colorado on October 30th, 2014 for the purpose of leasing to licensed Cannabis and Hemp growers. The decision was made based on increased demand for medical and recreational cannabis and loosening of some restrictions in Colorado. Since the purchase the value of the property has increased 1400%, making it one of the most valuable assets held by the company.
The Company will finance and build cutting-edge grow facilities for qualified licensed participants using HempTech technologies. Due to the large available acreage on the purchased land, we foresee multiple multi-million dollar large grow facilities and vast agricultural space available for farming hemp. The Company will grow Hemp for its own production in the near future. FutureLand also plans on similar projects in other legal cannabis states.
On December 2014, FutureLand Properties entered into a land and greenhouse lease agreement with Colorado Flower Company, LTD, a Colorado LLC, for the growing of medical and recreational cannabis. The master lease agreement calls for six figure monthly lease payments for the land, the greenhouse and the technology. The Commercial Agreement is for five (5) years and for a consideration of $370,000 per month. As we build other grow facilities, we will expand our revenue exponentially for FutureLand and its parent company, FutureWorld Corp.
2. URVape, Inc.
URVape was started to contribute to the current revolution, which has become an international phenomenon, known as the “Vaping” industry. After studying the marketplace, with more than 466 vendors attempting to reach nicotine consumers, we recognized early on that there were unsupported claims and deficiencies in the products and e-liquids being sold. As a result, URVape has dedicated itself to providing products that are free of any substances which, when heated for vaping, could be harmful. Through our in-house Product Development personnel, and through the hiring of a consultant whose area of expertise is microbiology, specific to cannabis and vaping, we have developed two primary device changes that are being patented.
The goal is to become the market leader of safe vaping materials. To that end, URVape has Trademarked “SafeVape” for use in describing the technologies utilized in bringing both devices and e-liquids to the marketplace. The E-cigarette, Cannabis and Herbal vaping industry is an ever growing and evolving industry. We are fortunate to be part of this historical moment in time where consumers around the globe will finally have access to natural plant derivatives to enhance their health and enjoyment without the inherent side effects of synthetic medicines.
So after months of redevelopment, URVape will be introducing “SafeVape” products in the beginning of February, 2015. With the unveiling of our new products, URVape will ramp up production selling vaporizer pens in legal cannabis states in conjunction with licensed cannabis extract (oil) and hemp (CBD) providers. The company has recently signed a major agreement with such a provider in the state of Colorado and expects to sign more agreements in the coming months.
3. CB scientific, Inc.
CB scientific, located in Denver Colorado, has introduced the most technologically advanced product in the entire industry; PocketLabs or PersonalAnalytics for THC and CBD. These personal test kits have allowed individuals and companies the instant power to test their products for potency and viability without the need for expensive and time consuming labs. The extent of this innovation was appreciated recently by industry insiders when PersonalAnalytics was awarded “2014 Product of The Year” after only 94 days since product launch.
So far, we have sold thousands of the kits all around the country and we expect to heavily increase our sales even further in 2015 by signing substantial distribution agreements with major distributers and promoters, selling thousands more kits per month in 2015. CB scientific has created a niche in a segment which was non-existent only few months prior. CB scientific is on track to contribute heftily to the Company’s bottom line as it expands its current product lines and opens up new ones.
4. HempTech Corp.
HempTech Corp has several products available right now specifically geared to helping cultivators of industrial hemp and medical cannabis to maximize yields while helping to control costs. HempTech products includes CaNNaLyTiX(TM) , SPIDer(TM) , SmartSense(TM), SmartNergy, and CaNNaTRAK(TM). HempTech has developed key technologies using sensor automation and big data to create grow profiles on successful cannabis/hemp strains. This revolutionary model would allow the growers to replicate cannabis strains for profitability and effectiveness. We are in the process of showcasing our products to major grow facilities.
Since our last update, HempTech has signed a major Commercial Agreement with a grower in Colorado to provide high-tech automation solutions to control all processes in the greenhouse based on HempTech’s state-of-the-art technologies. The Commercial Agreement is for five (5) years and for consideration of $205,000 per month. We expect similar agreements in the coming months from other grow facilities which will make HempTech one of the largest providers of grow technology to the cannabis/hemp industry and beyond.
5. NutraCann Labs, Inc.
Although you may have heard about this new subsidiary, FutureWorld has organized a new company to manage the extensive interest in our new line of CBD oil called “Essence”. CBD market is currently a $300M industry and growing at a dizzying pace. It is estimated to reach in billions by 2018.
We have factored (pharmaceutical grade) CBD oil to be one of the greatest revenue generating potentials for our company going forward. Initial retail sales will be through 1ml cartridges, 10ml & 50ml bottles and starter kits with the sleek URVape vaporizer pen. Bulk rate kilograms will also be available at the wholesale level. We have plans to increase distribution of the CBD oil up to 1000 Kilograms by the end of the year, making it our most profitable endeavor thus far.
